跳至主要内容
临床试验/KCT0008557
KCT0008557招募中Unknown

Add-on effect and safety of pharmacopuncture therapy and acupotomy in the treatment of patients with lumbar spinal stenosis : a pragmatic assessor-blinded, randomized, controlled trial

Korea Institute of Oriental Medicine0 个研究点目标入组 104 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40(Year) 至 75(Year)(—)
性别
All

入选标准

  • 1) aged 40 years and older but younger than 75 years
  • 2) confirmed to have lumbar spinal stenosis on imaging examination (CT or MRI)
  • - In cases where there is no existing imaging data or re-imaging is necessary, L-spine CT examination will be performed
  • 3) pain or discomfort in the lumbar, lower limb, or buttock = VAS 40mm
  • 4) Individuals who have clinical manifestations of lumbar spinal stenosis, such as neurogenic claudication or symptoms that change with posture
  • 5) Individuals who have received a final diagnosis of lumbar spinal stenosis based on comprehensive physical examination, medical history, and imaging examination results
  • 6) Individuals who voluntarily decide to participate after being informed of the study purpose and procedure and provide written informed consent

排除标准

  • 1) Individuals diagnosed with congenital or developmental lumbar spinal stenosis
  • 2) Individuals diagnosed with spinal disorders other than lumbar spinal stenosis, which may cause lower back pain and radiating pain (e.g., vertebral tumors, Cauda equina syndrome, spinal infections, ankylosing spondylitis)
  • 3) Individuals with structural problems in the spine that may cause lower back pain and radiating pain (e.g., acute thoracolumbar fractures, spinal dislocation, spondylolisthesis)
  • 4) Individuals with a history of spinal surgery, such as spinal fusion or laminectomy
  • 5) Individuals taking anticoagulants or antiplatelet drugs, or with bleeding disorders that may affect hemostasis
  • 6) Individuals with acupuncture hypersensitivity, metal allergies, severe atopic dermatitis, keloid skin, or other skin hypersensitivity
  • 7) Individuals with chronic diseases (e.g., chronic kidney disease, diabetic neuropathy, stroke and myocardial infarction, dementia, epilepsy) that may affect treatment outcomes or research results
  • 8) Individuals taking medications (e.g., steroids, immunosuppressants) that may affect treatment outcomes or research results
  • 9) Individuals with significant neuropsychiatric medical history or current illness
  • 10) Individuals with a history of alcoholism or drug abuse
  • 11) Pregnant or lactating women or those planning to become pregnant
  • 12) Individuals who are unable to self-report consent/data or require assistance from a caregiver/researcher to do so
  • 13) Other individuals deemed inappropriate by the clinical research coordinator

研究者

相似试验